Cargando…
Corrigendum: Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice
Autores principales: | Huang, Yichun, Zheng, Yinghui, Yang, Fengmei, Feng, Yicheng, Xu, Kunyao, Wu, Jun, Qu, Shuang, Yu, Zhexiong, Fan, Fu, Huang, Lu, Qin, Meng, He, Zhanlong, Nie, Kaili, So, Kwok-Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714637/ https://www.ncbi.nlm.nih.gov/pubmed/36467734 http://dx.doi.org/10.3389/fcimb.2022.1021676 |
Ejemplares similares
-
Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice
por: Huang, Yichun, et al.
Publicado: (2022) -
Effects of Lycium barbarum glycopeptide on renal and testicular injury induced by di(2-ethylhexyl) phthalate
por: Zhou, Xianling, et al.
Publicado: (2022) -
The Protective Effects of Lycium Barbarum Polysaccharides on Transient Retinal Ischemia
por: Yang, Di, et al.
Publicado: (2011) -
Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
por: Yao, Jian, et al.
Publicado: (2023) -
A Systematic Review of Potential Therapeutic Use of Lycium Barbarum Polysaccharides in Disease
por: Kwok, Sum Sum, et al.
Publicado: (2019)